TMEM270
geneOn this page
Also known as MGC26719
Summary
TMEM270 (transmembrane protein 270, HGNC:23018) is a protein-coding gene on chromosome 7q11.23, encoding Transmembrane protein 270 (Q6UE05).
Predicted to be located in membrane.
Source: NCBI Gene 135886 — RefSeq curated summary.
At a glance
- GWAS associations: 4
- Clinical variants (ClinVar): 50 total — 1 pathogenic
- Phenotypes (HPO): 186
- MANE Select transcript:
NM_182504
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:23018 |
| Approved symbol | TMEM270 |
| Name | transmembrane protein 270 |
| Location | 7q11.23 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | MGC26719 |
| Ensembl gene | ENSG00000175877 |
| Ensembl biotype | protein_coding |
| OMIM | 612547 |
| Entrez | 135886 |
Gene structure
Transcript identifiers
Ensembl transcripts: 2 — 1 protein_coding, 1 nonsense_mediated_decay
ENST00000320531, ENST00000426490
RefSeq mRNA: 1 — MANE Select: NM_182504
NM_182504
CCDS: CCDS43597
Canonical transcript exons
ENST00000320531 — 3 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001221927 | 73865577 | 73865890 |
| ENSE00001221934 | 73861159 | 73861266 |
| ENSE00003586319 | 73864993 | 73865421 |
Expression profiles
Bgee: expression breadth broad, 64 present calls, max score 94.80.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.0286 / max 26.6140, expressed in 4 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 79031 | 0.0286 | 4 |
Top tissues by expression
213 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| right testis | UBERON:0004534 | 94.80 | gold quality |
| left testis | UBERON:0004533 | 94.73 | gold quality |
| testis | UBERON:0000473 | 91.31 | gold quality |
| sperm | CL:0000019 | 88.44 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 81.99 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 63.20 | gold quality |
| adult organism | UBERON:0007023 | 62.12 | gold quality |
| right uterine tube | UBERON:0001302 | 57.37 | gold quality |
| cardiac muscle of right atrium | UBERON:0003379 | 54.34 | gold quality |
| left ventricle myocardium | UBERON:0006566 | 54.23 | gold quality |
| kidney epithelium | UBERON:0004819 | 53.93 | gold quality |
| epithelial cell of pancreas | CL:0000083 | 53.55 | gold quality |
| upper arm skin | UBERON:0004263 | 53.52 | gold quality |
| cerebellar vermis | UBERON:0004720 | 52.64 | gold quality |
| nasal cavity mucosa | UBERON:0001826 | 52.06 | gold quality |
| pancreatic ductal cell | CL:0002079 | 50.96 | silver quality |
| myocardium | UBERON:0002349 | 50.25 | gold quality |
| lower lobe of lung | UBERON:0008949 | 50.07 | silver quality |
| tibialis anterior | UBERON:0001385 | 49.08 | silver quality |
| mucosa of transverse colon | UBERON:0004991 | 47.44 | gold quality |
| deltoid | UBERON:0001476 | 47.26 | gold quality |
| nasal cavity epithelium | UBERON:0005384 | 47.03 | gold quality |
| quadriceps femoris | UBERON:0001377 | 46.47 | gold quality |
| right lobe of liver | UBERON:0001114 | 46.04 | silver quality |
| vastus lateralis | UBERON:0001379 | 45.47 | gold quality |
| ileal mucosa | UBERON:0000331 | 45.21 | silver quality |
| saphenous vein | UBERON:0007318 | 44.80 | gold quality |
| fallopian tube | UBERON:0003889 | 44.15 | gold quality |
| duodenum | UBERON:0002114 | 43.71 | gold quality |
| layer of synovial tissue | UBERON:0007616 | 43.55 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 0.98 |
Regulation
Is transcription factor: no
Upstream regulators (CollecTRI, top): AR
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Tmem270 | ENSMUSG00000040576 |
| rattus_norvegicus | Tmem270 | ENSRNOG00000001474 |
Protein
Protein identifiers
Transmembrane protein 270 — Q6UE05 (reviewed: Q6UE05)
Alternative names: Williams-Beuren syndrome chromosomal region 28 protein
All UniProt accessions (1): Q6UE05
UniProt curated annotations — full annotation on UniProt →
Subcellular location. Membrane.
Miscellaneous. May be produced at very low levels due to a premature stop codon in the mRNA, leading to nonsense-mediated mRNA decay.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q6UE05-1 | 1 | yes |
| Q6UE05-2 | 2 |
RefSeq proteins (1): NP_872310* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR029166 | WBS28 | Family |
Pfam: PF15164
UniProt features (12 total): sequence variant 4, transmembrane region 3, splice variant 2, chain 1, region of interest 1, compositionally biased region 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q6UE05-F1 | 66.82 | 0.06 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 450 (showing top):
TGACCTY_ERR1_Q2, GGGTGGRR_PAX4_03, YGACNNYACAR_UNKNOWN, ATF3_Q6, chr7q11, RFX1_02, ER_Q6_02, ZWANG_TRANSIENTLY_UP_BY_2ND_EGF_PULSE_ONLY, GSE13522_WT_VS_IFNG_KO_SKIN_UP, PAX3_TARGET_GENES, HP_RECURRENT_URINARY_TRACT_INFECTIONS, HP_ABNORMALITY_OF_THE_BLADDER, HP_BLADDER_DIVERTICULUM, HP_INGUINAL_HERNIA, HP_CRYPTORCHIDISM
GO Biological Process (0):
GO Molecular Function (0):
GO Cellular Component (1): membrane (GO:0016020)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
172 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| TMEM270 | TMEM225 | Q6GV28 | 688 |
| TMEM270 | METTL27 | Q8N6F8 | 586 |
| TMEM270 | TBL2 | Q9Y4P3 | 582 |
| TMEM270 | TRIM50 | Q86XT4 | 572 |
| TMEM270 | GTSF1L | Q9H1H1 | 572 |
| TMEM270 | GARIN1B | Q96KD3 | 571 |
| TMEM270 | SPATS1 | Q496A3 | 552 |
| TMEM270 | FSCN3 | Q9NQT6 | 532 |
| TMEM270 | SPATA3 | Q8NHX4 | 531 |
| TMEM270 | GTF2IRD1 | Q9UHL9 | 511 |
| TMEM270 | DNAJC30 | Q96LL9 | 507 |
| TMEM270 | SPACA4 | Q8TDM5 | 500 |
| TMEM270 | PGPEP1L | A6NFU8 | 479 |
| TMEM270 | BUD23 | O43709 | 479 |
| TMEM270 | KIAA1217 | Q5T5P2 | 477 |
IntAct
2 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| TMEM270 | LDAF1 | psi-mi:“MI:0915”(physical association) | 0.400 |
BioGRID (2): TMEM159 (Affinity Capture-MS), WBSCR28 (Affinity Capture-Luminescence)
ESM2 similar proteins: A0A096P2H6, A0A0D9S1R4, A0A140LIA7, A0A2Y9GDB5, E1C7U0, P06759, P08700, P0DKU6, P0DKW1, P0DKW2, P0DKW3, P0DKW4, P0DKY3, P0DML4, P0DML5, P0DML6, P0DMN8, P0DOC4, P0DP53, P0DTG9, P0DTH0, P0DTH1, P0DTH2, P0DTH3, P0DTH4, P0DUP5, P0DUP6, P24001, P55056, P55057, P55797, Q0VCT2, Q13790, Q28809, Q3SYR5, Q3ZRW9, Q5HZE8, Q5JTB6, Q5JX69, Q5M889
Diamond homologs: Q2TBQ4, Q6UE05, Q6UJB9
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
50 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 1 |
| Likely pathogenic | 0 |
| Uncertain significance | 41 |
| Likely benign | 6 |
| Benign | 1 |
Top pathogenic / likely-pathogenic (1)
| Variant ID | HGVS | Classification |
|---|---|---|
| 563399 | GRCh37/hg19 7q11.23(chr7:72576872-74175429)x3 | Pathogenic |
SpliceAI
562 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 7:73863892:TTCA:T | donor_gain | 1.0000 |
| 7:73864991:A:AG | acceptor_gain | 1.0000 |
| 7:73864991:AGTT:A | acceptor_gain | 1.0000 |
| 7:73864992:G:GG | acceptor_gain | 1.0000 |
| 7:73864992:GTTG:G | acceptor_gain | 1.0000 |
| 7:73865077:G:GT | donor_gain | 1.0000 |
| 7:73861265:TGG:T | donor_loss | 0.9900 |
| 7:73861266:GGTG:G | donor_loss | 0.9900 |
| 7:73861267:G:GA | donor_loss | 0.9900 |
| 7:73861268:TGAG:T | donor_loss | 0.9900 |
| 7:73861269:GA:G | donor_loss | 0.9900 |
| 7:73864989:GCAGT:G | acceptor_loss | 0.9900 |
| 7:73864990:CA:C | acceptor_loss | 0.9900 |
| 7:73864991:A:C | acceptor_loss | 0.9900 |
| 7:73864992:G:GT | acceptor_loss | 0.9900 |
| 7:73864992:GT:G | acceptor_gain | 0.9900 |
| 7:73864992:GTT:G | acceptor_gain | 0.9900 |
| 7:73865101:C:T | donor_gain | 0.9900 |
| 7:73865412:GCTCA:G | donor_gain | 0.9900 |
| 7:73865417:G:GG | donor_gain | 0.9900 |
| 7:73864991:AGTTG:A | acceptor_gain | 0.9800 |
| 7:73864992:GTTGG:G | acceptor_gain | 0.9800 |
| 7:73865119:G:GT | donor_gain | 0.9800 |
| 7:73865571:TTCCA:T | acceptor_loss | 0.9800 |
| 7:73865572:TCCA:T | acceptor_loss | 0.9800 |
| 7:73865574:CA:C | acceptor_loss | 0.9800 |
| 7:73865575:A:AT | acceptor_loss | 0.9800 |
| 7:73861254:GCTC:G | donor_gain | 0.9700 |
| 7:73861263:GCTG:G | donor_gain | 0.9700 |
| 7:73865055:C:CG | donor_gain | 0.9700 |
AlphaMissense
1662 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 7:73865730:T:C | F219L | 0.983 |
| 7:73865732:T:A | F219L | 0.983 |
| 7:73865732:T:G | F219L | 0.983 |
| 7:73865037:G:C | K39N | 0.949 |
| 7:73865037:G:T | K39N | 0.949 |
| 7:73865691:T:A | W206R | 0.941 |
| 7:73865691:T:C | W206R | 0.941 |
| 7:73865731:T:G | F219C | 0.941 |
| 7:73865047:T:C | F43L | 0.940 |
| 7:73865049:C:A | F43L | 0.940 |
| 7:73865049:C:G | F43L | 0.940 |
| 7:73865716:T:C | L214P | 0.926 |
| 7:73865700:T:C | C209R | 0.908 |
| 7:73865731:T:C | F219S | 0.889 |
| 7:73865693:G:C | W206C | 0.887 |
| 7:73865693:G:T | W206C | 0.887 |
| 7:73865058:G:C | W46C | 0.879 |
| 7:73865058:G:T | W46C | 0.879 |
| 7:73865036:A:T | K39M | 0.878 |
| 7:73865048:T:C | F43S | 0.870 |
| 7:73865036:A:C | K39T | 0.866 |
| 7:73865719:T:C | L215P | 0.865 |
| 7:73865056:T:A | W46R | 0.863 |
| 7:73865056:T:C | W46R | 0.863 |
| 7:73865730:T:A | F219I | 0.859 |
| 7:73865727:G:C | A218P | 0.857 |
| 7:73865724:G:C | A217P | 0.854 |
| 7:73865702:C:G | C209W | 0.853 |
| 7:73865667:T:A | W198R | 0.846 |
| 7:73865667:T:C | W198R | 0.846 |
dbSNP variants (sampled 300 via entrez): RS1000812234 (7:73863336 C>T), RS1000926661 (7:73863550 C>A), RS1001155658 (7:73864617 T>G), RS1001268503 (7:73864882 A>G), RS1003006796 (7:73860404 T>A), RS1003055724 (7:73860103 C>T), RS1003281850 (7:73865743 C>G), RS1003342001 (7:73861559 C>G), RS1003392945 (7:73861376 G>A), RS1003895345 (7:73860374 C>T), RS1005050216 (7:73859663 T>C), RS1005349994 (7:73865467 G>T), RS1005490043 (7:73861361 C>A,G,T), RS1005789875 (7:73861112 C>G), RS1007048514 (7:73862429 C>T)
Disease associations
OMIM: gene MIM:612547 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
186 total (30 of 186 shown, HPO-id order):
| HPO | Term |
|---|---|
| HP:0000010 | Recurrent urinary tract infections |
| HP:0000014 | Abnormality of the bladder |
| HP:0000015 | Bladder diverticulum |
| HP:0000023 | Inguinal hernia |
| HP:0000025 | Functional abnormality of male internal genitalia |
| HP:0000028 | Cryptorchidism |
| HP:0000044 | Hypogonadotropic hypogonadism |
| HP:0000075 | Renal duplication |
| HP:0000076 | Vesicoureteral reflux |
| HP:0000083 | Renal insufficiency |
| HP:0000089 | Renal hypoplasia |
| HP:0000093 | Proteinuria |
| HP:0000121 | Nephrocalcinosis |
| HP:0000125 | Pelvic kidney |
| HP:0000147 | Polycystic ovaries |
| HP:0000154 | Wide mouth |
| HP:0000158 | Macroglossia |
| HP:0000179 | Thick lower lip vermilion |
| HP:0000212 | Gingival overgrowth |
| HP:0000232 | Everted lower lip vermilion |
| HP:0000252 | Microcephaly |
| HP:0000275 | Narrow face |
| HP:0000280 | Coarse facial features |
| HP:0000286 | Epicanthus |
| HP:0000307 | Pointed chin |
| HP:0000337 | Broad forehead |
| HP:0000343 | Long philtrum |
| HP:0000347 | Micrognathia |
| HP:0000348 | High forehead |
| HP:0000358 | Posteriorly rotated ears |
GWAS associations
4 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST007269_214 | Pulse pressure | 3.000000e-08 |
| GCST008839_198 | Height | 7.000000e-29 |
| GCST90014033_81 | Haemorrhoidal disease | 3.000000e-18 |
| GCST90020028_168 | Hip circumference adjusted for BMI | 6.000000e-09 |
EFO canonical traits (2, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0005763 | pulse pressure measurement |
| EFO:0008039 | BMI-adjusted hip circumference |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
18 total (human), top 18 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| sotorasib | affects cotreatment, increases expression | 1 |
| propionaldehyde | increases expression | 1 |
| butyraldehyde | increases expression | 1 |
| benzo(e)pyrene | decreases methylation | 1 |
| pentanal | increases expression | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| trametinib | affects cotreatment, increases expression | 1 |
| NVP-BKM120 | affects cotreatment, increases expression | 1 |
| Aldehydes | increases expression | 1 |
| Arsenic | affects methylation | 1 |
| Benzo(a)pyrene | increases methylation | 1 |
| Methapyrilene | decreases methylation | 1 |
| Silicon Dioxide | decreases expression | 1 |
| Dihydrotestosterone | decreases expression | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
| Aflatoxin B1 | decreases methylation | 1 |
| Cadmium Chloride | increases expression | 1 |
| Permethrin | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): hemorrhoid